Czech National Bank Has $4.13 Million Stake in STERIS plc (NYSE:STE)

Czech National Bank lifted its holdings in STERIS plc (NYSE:STE) by 8.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,829 shares of the medical equipment provider’s stock after acquiring an additional 1,443 shares during the quarter. Czech National Bank’s holdings in STERIS were worth $4,134,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the business. Global Retirement Partners LLC boosted its stake in STERIS by 9.4% in the first quarter. Global Retirement Partners LLC now owns 570 shares of the medical equipment provider’s stock worth $128,000 after purchasing an additional 49 shares in the last quarter. First Hawaiian Bank lifted its position in STERIS by 0.4% during the 1st quarter. First Hawaiian Bank now owns 13,857 shares of the medical equipment provider’s stock worth $3,115,000 after buying an additional 50 shares in the last quarter. Kentucky Retirement Systems Insurance Trust Fund grew its holdings in STERIS by 1.5% during the 4th quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 3,520 shares of the medical equipment provider’s stock worth $774,000 after acquiring an additional 53 shares during the last quarter. J.Safra Asset Management Corp increased its position in STERIS by 77.9% in the 1st quarter. J.Safra Asset Management Corp now owns 121 shares of the medical equipment provider’s stock valued at $27,000 after acquiring an additional 53 shares in the last quarter. Finally, Mather Group LLC. increased its position in STERIS by 7.6% in the 2nd quarter. Mather Group LLC. now owns 763 shares of the medical equipment provider’s stock valued at $172,000 after acquiring an additional 54 shares in the last quarter. 94.69% of the stock is currently owned by institutional investors.

STERIS Trading Down 0.7 %

Shares of NYSE:STE traded down $1.68 during midday trading on Monday, hitting $234.30. The company had a trading volume of 74,073 shares, compared to its average volume of 486,012. The firm has a fifty day simple moving average of $225.43 and a 200 day simple moving average of $223.04. The stock has a market cap of $23.16 billion, a price-to-earnings ratio of 61.53 and a beta of 0.83. The company has a current ratio of 3.08, a quick ratio of 2.36 and a debt-to-equity ratio of 0.49. STERIS plc has a 12 month low of $195.47 and a 12 month high of $243.37.

STERIS (NYSE:STE) last issued its earnings results on Tuesday, August 6th. The medical equipment provider reported $2.14 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.98 by $0.16. The firm had revenue of $1.28 billion for the quarter, compared to analysts’ expectations of $1.27 billion. STERIS had a return on equity of 13.89% and a net margin of 7.36%. The company’s revenue was down .4% compared to the same quarter last year. During the same quarter last year, the business earned $2.00 earnings per share. On average, analysts predict that STERIS plc will post 9.16 EPS for the current year.

STERIS Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 20th. Shareholders of record on Thursday, September 5th will be paid a $0.57 dividend. This represents a $2.28 annualized dividend and a yield of 0.97%. The ex-dividend date of this dividend is Thursday, September 5th. This is an increase from STERIS’s previous quarterly dividend of $0.52. STERIS’s dividend payout ratio is presently 59.69%.

Insiders Place Their Bets

In related news, VP Renato Tamaro sold 1,154 shares of the company’s stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $231.64, for a total value of $267,312.56. Following the completion of the sale, the vice president now owns 6,677 shares in the company, valued at approximately $1,546,660.28. The transaction was disclosed in a filing with the SEC, which is available through this link. Company insiders own 1.14% of the company’s stock.

Wall Street Analysts Forecast Growth

STE has been the topic of several research analyst reports. JMP Securities reissued a “market outperform” rating and set a $265.00 price target on shares of STERIS in a research note on Wednesday, August 7th. Needham & Company LLC reiterated a “hold” rating on shares of STERIS in a research report on Thursday. Stephens reissued an “overweight” rating and issued a $260.00 target price on shares of STERIS in a research note on Wednesday, August 7th. StockNews.com lowered STERIS from a “buy” rating to a “hold” rating in a research note on Monday, August 5th. Finally, Piper Sandler reiterated a “neutral” rating and issued a $225.00 price objective (up from $220.00) on shares of STERIS in a research report on Friday, May 10th. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $243.60.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.